Member Login
Market Reports
 |
|
EXECUTIVE SUMMARY Market by Technology Market by Clinical Application Leading MD&D Suppliers 1. CLINICAL APPLICATIONS OVERVIEW 1.1 Cardiovascular Disease 1.1.1 Prevalence and Mortality 1.1.2 Risk Factors 1.1.3 Financial Costs 1.1.4 Diagnosis 1.1.5 Treatment 1.1.6 Market Overview 1.2 Musculoskeletal Conditions (Orthopedics & Spine) 1.2.1 Diagnosis 1.2.2 Joint Reconstruction 1.2.3 Fractures 1.2.4 Back Pain 1.2.5 Market Overview 1.3 Oncology 1.3.1 Screening and Diagnosis 1.3.2 Treatment 1.3.3 Market Overview 1.4 Respiratory/Pulmonary Medicine 1.4.1 Chronic Obstructive Pulmonary Disease 1.4.1.1 Risk Factors, Diagnosis and Treatment 1.4.1.2 Statistics 1.4.2 Asthma 1.4.2.1 Diagnosis and Treatment 1.4.2.2 Statistics 1.4.3 Sleep Apnea 1.4.4 Market Overview 1.5 Urologic and Renal Medicine 1.5.1 Urologic Conditions 1.5.1.1 Benign Prostatic Hyperplasia 1.5.1.2 Prostatitis 1.5.1.3 Incontinence 1.5.2 Renal Conditions 1.5.2.1 Calculi 1.5.2.2 End-Stage Renal Disease 1.5.3 Market Overview 1.6 Diabetes 1.6.1 Statistics 1.6.2 Market Overview 1.7 Gastrointestinal Disorders 1.7.1 Diagnosis 1.7.2 Treatment 1.7.3 Market Overview 2. MAJOR MD&D MARKETS AND OPPORTUNITIES 2.1 MD&D Market Overview 2.2 In Vitro Diagnostics 2.2.1 Market Overview 2.2.1.1 Market by Geography 2.2.1.2 Market by Technology 2.2.1.3 Suppliers 2.3 Cardiovascular Therapy 2.3.1 Rhythm Management 2.3.1.1 Market by Technology 2.3.1.2 Market by Geography 2.3.1.3 Suppliers 2.3.2 Interventional and Endovascular Technologies 2.3.2.1 Market by Technology 2.3.2.1.1 Interventional Cardiology 2.3.2.1.2 Peripheral Vascular Products 2.3.2.1.3 Electrophysiology 2.3.2.1.4 Neurovascular 2.3.2.2 Market by Geography 2.3.2.3 Suppliers 2.4 Diagnostic Imaging 2.4.1 Diagnostic Imaging Systems 2.4.1.1 Market by Technology 2.4.1.1.1 Traditional X-Ray 2.4.1.1.2 Ultrasound 2.4.1.1.3 Computed Tomography 2.4.1.1.4 Magnetic Resonance Imaging 2.4.1.1.5 Positron Emission Tomography 2.4.1.2 Market by Geography 2.4.1.3 Suppliers 2.4.2 Contrast Agents and Radiopharmaceuticals 2.4.2.1 Market Analysis 2.4.2.2 Market by Geography 2.4.2.3 Suppliers 2.5 Orthopedics and Spinal Products 2.5.1 Reconstructive Implants 2.5.2 Spine 2.5.3 Trauma 2.6 Urology/Renal 2.6.1 End-Stage Renal Disease 2.6.2 Other Urology Markets 2.7 Drug Delivery 2.7.1 Market by Technology 2.7.2 Market by Geography 2.7.3 Suppliers 2.8 Endoscopy 2.8.1 Market by Technology 2.8.2 Market by Application 2.8.3 Market by Geography 2.8.4 Suppliers 2.9 Energy-Based Therapies 2.9.1 Market by Geography 2.9.2 Market by Application 2.9.3 Market by Technology 2.9.3.1 Radiotherapy 2.9.3.2 Radiofrequency Therapy 2.9.3.2.1 Applications and Suppliers 2.9.3.2.2 Sales by Geography 2.9.3.3 Laser and Other Light-Based Therapies 2.9.3.3.1 Market by Application 2.9.3.3.2 Market by Geography 2.9.3.3.3 Suppliers 2.9.3.4 Therapeutic Ultrasound 2.9.3.4.1 Harmonic Scalpel 2.9.3.4.2 HIFU 2.9.3.4.3 ESWT 2.9.3.5 Microwave Therapy 2.9.3.6 Cryotherapy 2.9.3.7 Hydrotherapy 2.10 Dental Products 2.10.1 Regional Dentists and Expenditures 2.10.2 Major Product Markets 2.10.2.1 Equipment 2.10.2.1.1 Dental Lasers 2.10.2.2 Consumables 2.10.2.3 Laboratory Products 2.10.2.4 Specialty Products 2.10.2.4.1 Orthodontics 2.10.2.4.2 Endodontics 2.10.2.4.3 Dental Implants 2.10.3 Suppliers 2.11 Ophthalmic Surgery 2.11.1 Market by Segment 2.11.1.1 Cataract and Vitreoretinal Surgery Products 2.11.1.2 Intraocular Lenses (IOLs) 2.11.1.3 Refractive Surgery Products 2.11.2 Suppliers 2.12 Hearing Devices 2.12.1 Distribution 2.12.2 Market by Geography 2.12.3 Suppliers 2.13 Wound Closure and Management 2.13.1 Sutures 2.13.2 Surgical Staples 2.13.3 Surgical Sealants and Glues (SSGs) 2.13.3.1 Fibrin Sealants 2.13.3.2 Hemostats 2.13.3.3 Adhesion Prevention 2.13.3.4 Topical Glue (Cyanoacrylates) 2.13.4 Strips 2.13.5 Automated Suturing Devices 2.13.6 Wound Management 2.13.6.1 Technologies 2.13.6.2 Suppliers 2.14 Critical Care Technologies 2.14.1 Market Trends 2.14.2 Market by Geography 2.14.3 Market by Technology 2.14.3.1 Anesthesia Delivery 2.14.3.2 Ventilators 2.14.3.3 Patient Monitoring 2.14.3.3.1 Pulse Oximetry 2.14.3.3.2 Other Segments 2.14.3.4 Blood Gas Analysis 2.15 Home Patient Monitoring 2.15.1 Market by Technology 2.15.2 Markey by Geography 2.15.3 Suppliers 2.16 Infection Control Equipment and Supplies 2.16.1 Approaches 2.16.2 Products and Trends 2.16.3 Markets by Technology 2.16.4 Geographic Distribution of Market 2.16.5 Suppliers 2.17 Surgical Tables, Lights and Ceiling Systems 2.17.1 Products and Technologies 2.17.1.1 Surgical Tables 2.17.1.2 Surgical Lighting Systems 2.17.1.3 Ceiling Systems 2.17.2 Market by Technology 2.17.3 Suppliers 2.18 Neuromodulation 2.18.1 Market by Technology 2.18.1.1 Neurostimulators 2.18.1.2 Implantable Drug Pumps 2.18.1.3 Cochlear Implants 2.18.2 Market by Geography 2.18.3 Suppliers 3.0 COUNTRY HEALTH CARE PROFILES 3.1 North American Health Care Systems 3.1.1 United States 3.1.1.1 Health Care Statistics Overview 3.1.1.2 Health Care Administration 3.1.1.3 Medical Device Market 3.1.1.4 Product Regulation and Reimbursement 3.1.2 Canada 3.1.2.1 Health Care Statistics Overview 3.1.2.2 Health Care Administration 3.1.2.3 Medical Device Market 3.1.2.4 Product Regulation and Reimbursement 3.2 Overview of European Health Care 3.2.1 Health Care Spending and Reform 3.2.2 Health Care Facilities and Manpower 3.2.3 Reimbursement 3.2.4 Impact of the European Community 3.2.4.1 EC Directives 3.2.4.2 Pricing 3.2.5 National Profiles 3.2.5.1 Germany 3.2.5.1.1 Healthcare System and Resources 3.2.5.1.2 DRG System 3.2.5.1.3 Proposed Legislation 3.2.5.2 France 3.2.5.2.1 Health Care System and Resources 3.2.5.2.2 Health Care Spending 3.2.5.2.3 Health Care Administration 3.2.5.2.4 Product Regulation 3.2.5.2.5 Product Reimbursement 3.2.5.2.6 French Medical Device Market 3.2.5.3 United Kingdom 3.2.5.3.1 Health Care Statistics Overview 3.2.5.3.2 National Health Service 3.2.5.3.3 Medical Products Regulation 3.2.5.3.4 Health Care Reforms 3.2.5.3.5 U.K. Medical Device Market 3.2.5.4 Italy 3.2.5.4.1 Emerging Private Sector 3.2.5.4.2 Product Issues 3.2.5.5 Spain 3.2.5.5.1 Health Care Funding and Delivery 3.2.5.5.2 Health Care Resources 3.2.5.5.3 Ambulatory Care Reforms 3.2.5.5.4 Product Issues 3.2.5.6 Belgium 3.2.5.6.1 Health Care Spending and Administration 3.2.5.6.2 Regulation & Reimbursement 3.2.5.6.3 Health Care Resources 3.2.5.7 The Netherlands 3.2.5.7.1 Health Care Overview 3.2.5.7.2 Health Care Resources 3.2.5.7.3 Health Care Spending and Programs 3.2.5.7.4 Health Care Administration 3.2.5.7.5 Product Issues 3.3 Other Europe 3.4 Japan 3.4.1 Structure of Health Insurance System 3.4.2 Health Care Spending and Legislation 3.4.3 Health Care Facilities 3.4.4 Health Manpower 3.4.5 Medical Device Market 3.4.6 Product Regulation and Reimbursement 3.5 Overview of Asia-Pacific Health Care (ex Japan) 3.5.1 Health Care Spending 3.5.2 Health Care Resources 3.5.3 Selected Country Overviews 3.5.3.1 China 3.5.3.2 India 3.5.3.3 Malaysia 3.5.3.4 Philippines 3.5.3.5 Singapore 3.5.3.6 South Korea 3.5.3.7 Thailand 3.6 Overview of Latin American Health Care 3.6.1 Brazil 3.6.2 Mexico 3.6.3 Argentina 4. COMPANY PROFILES 4.1 Abbott Laboratories 4.2 Alcon, Inc. 4.3 Baxter International, Inc. 4.4 Bayer Diagnostics 4.5 B. Braun Melsungen AG (Aesculap) 4.6 Becton, Dickinson & Company 4.7 Biomet, Inc. 4.8 Boston Scientific Corporation 4.9 Cardinal Health, Inc. 4.10 GE Healthcare 4.11 Guidant Corporation 4.12 Johnson & Johnson 4.13 Medtronic, Inc. 4.14 3M Company 4.15 Philips Medical 4.16 Olympus Corporation 4.17 Roche Diagnostics 4.18 Siemens AG 4.19 Smith & Nephew, plc 4.20 St. Jude Medical, Inc. 4.21 Stryker Corporation 4.22 Terumo Medical Corporation 4.23 Toshiba Medical Systems Corporation 4.24 Tyco International, Ltd. 4.25 Zimmer Holdings, Inc. PRELIMINARY LIST OF EXHIBITS Exhibit 1-1: Overview of Major Clinical Applications for MD&D Technology Exhibit 1-2: Overview of Major Heart and Circulatory Disorders in U.S., 2001 Exhibit 1-3: Estimated Costs of Cardiovascular Disease and Stroke, 2005 Exhibit 1-4: Approaches to Cardiovascular Disease Diagnosis Exhibit 1-5: Major Trends in Cardiovascular Disease Treatment Exhibit 1-6: Selected Data on Joint Replacement, 2003 Exhibit 1-7: Selected Global Spinal Procedures, 2003 and 2008 Exhibit 1-8: Selected Global Cancer Statistics Exhibit 1-9: Selected Respiratory Conditions Exhibit 1-10: Selected Urologic and Renal Conditions Exhibit 1-11: Diabetics by Geographic Region, 2000 and 2030 Exhibit 1-12: Countries with Largest Diabetic Populations, 2000 and 2030 Exhibit 2-1: Overview of Major MD&D Market Segments Exhibit 2-2: Global MD&D Market by Major Technology, 2004 Exhibit 2-3: Overview of In Vitro Diagnostic Market Segments Exhibit 2-4: Global IVD Market by Major Segment, 2004-2010 Exhibit 2-5: Geographic Distribution of Global IVD Market, 2004 & 2010 Exhibit 2-6: Global IVD Market by Technology, 2004-2010 Exhibit 2-7: Global IVD Market, Supplier Shares, 2004 Exhibit 2-8: Global Market for Molecular Diagnostics, Supplier Shares, 2004 Exhibit 2-9: Global Market for IVD Diabetes Care, Supplier Shares, 2004 Exhibit 2-10: Overview of Cardiac Rhythm Management Segments Exhibit 2-11: Global Cardiac Rhythm Sales by Technology, 2004-2010 Exhibit 2-12: Cardiac Rhythm Sales by Geography, 2004 Exhibit 2-13: Cardiac Rhythm Management, Supplier Shares, 2001-2005 Exhibit 2-14: Global Pacemaker Supplier Shares, 2004 Exhibit 2-15: Global ICD Supplier Shares, 2004 Exhibit 2-16: Overview of Endovascular Therapeutic Segments Exhibit 2-17: Interventional and Endovascular Technologies Market by Segment, 2004-2010 Exhibit 2-18: Worldwide Coronary Stent Sales by Company, 2001-2005 Exhibit 2-19: Interventional and Endovascular Market, Supplier Shares, 2004 Exhibit 2-20: Overview of Diagnostic Imaging Segments Exhibit 2-21: Global Diagnostic Imaging Market by Segment, 2004-2010 Exhibit 2-22: Global Diagnostic Imaging Market by Geography, 2004 & 2010 Exhibit 2-23: Diagnostic Imaging Systems, Supplier Shares, 2004 Exhibit 2-24: Contrast Agents and Radiopharmaceuticals Market, 2004-2010 Exhibit 2-25: Contrast Agents and Radiopharmaceuticals Market by Geography, 2004 and 2010 Exhibit 2-26: Contrast Agents & Radiopharmaceuticals, Supplier Shares, 2004 Exhibit 2-27: Overview of Orthopedic Market Segments Exhibit 2-28: Global Sales of Orthopedic Products by Segment, 2004-2010 Exhibit 2-29: Reconstructive Implants, Supplier Shares, 2001-2005 Exhibit 2-30: Global Spine Sales by Major Technology Segment, 2004-2010 Exhibit 2-31: Global Spine Market by Geography, 2004 Exhibit 2-32: Global Spine Market, Supplier Shares, 2002-2004 Exhibit 2-33: Global Trauma Sales by Segment, 2004 Exhibit 2-34: Global Trauma Sales by Geography, 2004 Exhibit 2-35: Global Trauma Products, Supplier Shares, 2002-2004 Exhibit 2-36: Overview of Urology Market Segments Exhibit 2-37: Global Hemodialysis Statistics, 2004 Exhibit 2-38: Global Dialysis Sales by Geography, 2004 Exhibit 2-39: Global Dialysis Patients & Product Sales, 2004-2010 Exhibit 2-40: ESRD Products, Supplier Shares, 2004 Exhibit 2-41: Other Urology and Renal Product Markets by Segment, 2004-2010 Exhibit 2-42: Overview of Drug Delivery Market Segments Exhibit 2-43: Global Drug Delivery Market by Technology, 2004-2010 Exhibit 2-44: Drug Delivery Sales by Geography, 2004 Exhibit 2-45: Drug Delivery Products, Supplier Shares, 2004 Exhibit 2-46: Overview of Endoscopy Market Segments Exhibit 2-47: Global Endoscopy Products by Type & Application, 2004-2010 Exhibit 2-48: Global Endoscopy Sales by Geography, 2004 Exhibit 2-49: Endoscopy Market, Supplier Shares, 2004 Exhibit 2-50: Energy-Based Therapies, Technology Overview Exhibit 2-51: Energy-Based Therapy Sales by Geography, 2004 Exhibit 2-52: Energy-Based Therapy Sales by Application, 2004 Exhibit 2-53: Energy-Based Therapy Sales by Technology, 2004-2010 Exhibit 2-54: Overview of Radiotherapy Technologies Exhibit 2-55: Global Radiotherapy Capital Equipment Sales by Supplier, 2004 Exhibit 2-56: Global Brachytherapy Seed Sales by Supplier, 2004 Exhibit 2-57: Global RF Therapy Sales by Supplier, 2004 Exhibit 2-58: Global RF Therapy Sales by Application, 2004 Exhibit 2-59: Global RF Therapy Sales by Geography Exhibit 2-60: Laser and Light Based Therapy Sales by Application, 2004 Exhibit 2-61: Global Laser and Light-Based Therapy Sales by Geography, 2004 Exhibit 2-62: Global Laser and Light-Based Therapy Sales, Supplier Shares, 2004 Exhibit 2-63: Therapeutic Ultrasound Sales by Segment, 2004-2010 Exhibit 2-64: Microwave Therapy Sales byApplication, 2004 Exhibit 2-65: Global Microwave System Sales, Supplier Shares, 2004 Exhibit 2-66: Global Cryotherapy Sales by Application, 2004 Exhibit 2-67: Global Dental Products Market by Segment, 2004 and 2010 Exhibit 2-68: Dentists and Product Outlays by Major Region, 2004 Exhibit 2-69: Global Dental Market, Supplier Shares, 2004 Exhibit 2-70: Global Ophthalmic Surgery Products, Market Forecast by Segment, 2004-2010 Exhibit 2-71: Overview of Ophthalmic Surgery Segments Exhibit 2-72: Global Ophthalmic Surgery Sales, Supplier Shares, 2004 Exhibit 2-73: Global Hearing Device Sales, 2004-2010 Exhibit 2-74: Global Hearing Device Sales by Geography, 2004 Exhibit 2-75: Global Hearing Device Sales, Supplier Shares, 2002-2004 Exhibit 2-76: Overview of Wound Care Market Segments Exhibit 2-77: Global Wound Care Sales by Segment, 2004-2010 Exhibit 2-78: Global Wound Care Sales, Supplier Shares, 2004 Exhibit 2-79: Global Wound Care Sales by Geography, 2004 Exhibit 2-80: Global Surgical Suture Sales by Major Supplier, 2004 Exhibit 2-81: Global Surgical Staple Sales by Major Supplier, 2004 Exhibit 2-82: Surgical Sealants and Glues, Overview Exhibit 2-83: Global Surgical Sealant and Glue Sales by Segment, 2004-2010 Exhibit 2-84: Global Strip Sales by Geography, 2004 and 2010 Exhibit 2-85: Global Wound Management Sales, Supplier Shares, 2004 Exhibit 2-86: Overview of Critical Care Technology Segments Exhibit 2-87: Critical Care Technologies, Sales by Geography, 2004 Exhibit 2-88: Critical Care Technologies, Sales by Segment, 2004-2010 Exhibit 2-89: Anesthesia Delivery, Supplier Shares, 2004 Exhibit 2-90: Global Ventilator Sales, Supplier Shares, 2004 Exhibit 2-91: Global Patient Monitoring Sales, Supplier Shares, 2004 Exhibit 2-92: Blood Gas Analysis, Supplier Shares, 2004 Exhibit 2-93: Overview of Home Patient Monitoring Segments Exhibit 2-94: Home Patient Monitoring Market by Segment, 2004-2010 Exhibit 2-95: Home Patient Monitoring, Supplier Shares, 2004 Exhibit 2-96: Comparison of Major Sterilization Methods Exhibit 2-97: Selected Types of Infection Control Products Exhibit 2-98: Infection Control Sales by Geography, 2004 Exhibit 2-99: Global Infection Control Equipment and Consumables, Sales by Segment, 2003-2010 Exhibit 2-100: Infection Control Products, Supplier Shares, 2004 Exhibit 2-101: Overview of Surgical Tables, Lighting and Ceiling Systems Exhibit 2-102: Surgical Tables, Lighting and Ceiling Systems, Market Forecast, 2004-2010 Exhibit 2-103: Surgical Tables, Lights & Ceiling Systems, Supplier Shares by Technology, 2004 Exhibit 2-104: Overview of Neuromodulation Technologies and Applications Exhibit 2-105: Global Neuromodulation Market by Segment, 2004-2010 Exhibit 2-106: Global Neuromodulation Sales by Geography, 2004 Exhibit 2-107: Global Neuromodulation Sales, Supplier Shares, 2004 Exhibit 3-1: United States, Health Care Profile Exhibit 3-2: United States, Health Expenditures as Share of GDP, 1998-2003 Exhibit 3-3: Canada, Health Care Profile Exhibit 3-4: Canada, Health Expenditures as Share of GDP, 1998-2003 Exhibit 3-5: Health Care Expenditures by Country, 2003 Exhibit 3-6: Physicians by Country, 2003 Exhibit 3-7: Acute Care Hospital Beds and Utilization, 2003 Exhibit 3-8: Germany, Health Care Profile Exhibit 3-9: Germany, Health Expenditures as Share of GDP, 1998-2003 Exhibit 3-10: Distribution of Statutory Health Insurance Expenditures, 2003 Exhibit 3-11: France, Health Care Profile Exhibit 3-12: France, Health Expenditures as Share of GDP, 1998-2003 Exhibit 3-13: United Kingdom, Health Care Profile Exhibit 3-14: United Kingdom, Health Expenditures as Share of GDP, 1998-2003 Exhibit 3-15: Italy, Health Care Profile Exhibit 3-16: Italy, Health Expenditures as Share of GDP, 1998-2003 Exhibit 3-17: Health Care Profile, Spain Exhibit 3-18: Spain, Health Expenditures as Share of GDP, 1998-2003 Exhibit 3-19: Belgium, Health Care Profile Exhibit 3-20: Belgium, Health Expenditures as Share of GDP, 1998-2003 Exhibit 3-21: The Netherlands, Health Care Profile Exhibit 3-22: Annual Trend in Dutch Health Expenditures as Share of GDP Exhibit 3-23: Selected Other European Nations, Health Care Indicators Exhibit 3-24: Overview of Japanese Health Insurance Programs Exhibit 3-25: Comparison of Three Major Japanese Health Insurance Programs Exhibit 3-26: Japan, Health Expenditures as Share of GDP, 1998-2003 Exhibit 3-27: Overview of Japan's Health Facilities and Personnel Exhibit 3-28: Health Care Indicators for Selected Asia Pacific Nations Exhibit 3-29: Health Care Resources in Selected Asia-Pacific Nations Exhibit 3-30: Per Capita Mortality Rates by Type Among Selected Latin American Regions Exhibit 3-31: Per Capita Health Care Resources in Selected Latin American Regions Exhibit 3-32: National Health Care Spending in Latin America, 2004 *** This is a partial list of companies, for a full listing request it ***
* Single License allows for report sharing within one company location.
The global medical device and diagnostics (MD&D) industry generated nearly $220 billion in revenues in 2005, of which nearly one-half were concentrated in four major technology segments - in vitro diagnostics (IVD), cardiovascular disease therapies, diagnostic imaging equipment, services and contrast, and orthopedic and spinal products. The aging of the global population, which will be accompanied by increases in cardiovascular disease, musculoskeletal conditions, cancer and other degenerative conditions, will drive future MD&D growth, including the development of technologies designed to diagnose and treat conditions less invasively at an earlier stage. The result will be a healthy 7.5% annual increase in MD&D sales to $312 billion in 2010, led by spinal products, neuromodulation devices, sleep apnea products, advanced molecular diagnostics, cardiac rhythm management products, orthopedic implants, endoscopy devices and energy-based technologies.
This 600-page report contains 156 exhibits describing the critical demographic, clinical, product and health delivery factors driving the global MD&D market. Individual market, geographic and competitive assessments are provided for 18 MD&D technologies, including cardiovascular technologies; in vitro diagnostics; orthopedics and spine; diagnostic imaging; urology/renal; wound management; dental; ophthalmic surgery; critical care; energy-based therapies; and endoscopy, among others. These are complemented by statistics and discussions of the 10 major clinical applications driving use of MD&D products, e.g., cardiovascular disease, musculoskeletal disease, cancer, diabetes, end-stage renal disease, and respiratory conditions. The market models built from the demand side have been compared with and verified by supply-side data developed through detailed analyses of MD&D sales by more than 350 companies, 27 of which are profiled in the report.
3M
Abbott Laboratories
Alcon
B. Braun
Baxter
Bayer Diagnostics
Beckman Coulter
Becton Dickinson
Biomerieux
Biomet
Boston Scientific
Bracco
Bristol Myers Squibb
C.R. Bard
Cardinal Health
Coloplast
Dade Behring
Denstply
Drager AG
Eastman Kodak
Edwards Lifesciences
Fresenius
Fuji Medical Systems
Gambro
GE Healthcare
Getinge
Guidant
Hartmann Group
Hill-Rom
Hitachi Medical
Hospira
Invacare
Johnson & Johnson
Kimberly Clark
Medtronic
Olympus
Philips
Respironics
Roche Diagnostics
Schering AG Group
Siemens Medical
Smith & Nephew
St. Jude Medical
Stryker
Synthes
Terumo
Toshiba Medical
Tyco
Varian Medical Systems
Zimmer
Plus 250+ Other Companies ...
+ MORE
** Corporate License allows for report sharing within all company locations.
This report is listed in the following markets:
Aesthetics, Biomaterials, Biotechnology, Cardiovascular, Dental, Diagnostics, Drug Delivery, Endocrine, Gastroenterology, Gynecology, Imaging, Neurology, Oncology, Ophthalmology, Orthopedics, Pain Management, Patient Management, Procedure Volumes, Disease Incidence & Prevalence, Respiratory, Spine, Surgery, Urology, Vascular and Wound Management